Companies / KALA BIO, Inc.

KALA BIO, Inc.

Nasdaq: KALACIK 1479419ARLINGTON, MAkalarx.com ↗

Financials · FY2017

Revenue$0
Net income$-26.98M
Total debt$26.95M
Cash$1.76M
Diluted EPS$-3.31
Shares outstanding18.6M

Ownership

18.6M shares outstanding · as of May 14, 2026
0.38%Institutions
Ownership
Institutions0.38%71,542
Public float99.62%18,518,290

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Berger Chaim D.FormerDirector
——
Colman Yonatan C.FormerDirector
——
Minkowitz AvrahamCEOFormerChief Executive Officer · Director
——
Posen Hillel D.FormerDirector
——
Purdy Brendan P.FormerDirector
——

Institutional holders 1

View all →
HolderValue% of shares
BlackRock, Inc.$123.8K0.38%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Baker Bros. Advisors LPPassive13G/A———
LifeSci Capital LLCPassive13G———
Baker Bros. Advisors LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
KALA——483119301—